Skip to content

The Aesthetic Surgery Education and Research Foundation

Published
Breast Implant Illness: An Expert-Panel Discussion on Current Research Print
Jeffrey M Kenkel, MD, FACS, Caroline Glicksman, MD, MSJ, Patricia McGuire, MD, Luis M Rios, Jr., MD, William P Adams, Jr., MD

Aesthetic Surgery Journal Open Forum, Volume 3, Issue 3, September 2021, ojab027

Background: The authors are pleased to present an expert roundtable discussion on breast implant illness (BII) (Video). The discussants include a panel of leading experts in aesthetic surgery, and the roundtable was recorded live at The Aesthetic Meeting 2021 in Miami Beach, FL, USA. The panelists provide an overview of the current challenges, areas of research, and education being undertaken to better understand the symptoms of BII and how they present in various patient populations. They discuss not only the physical indications of BII but also the emotional and psychological implications that confound its diagnosis and treatment. Finally, the panelists discuss the contributions of The Aesthetic Society and the Aesthetic Surgery Education and Research Foundation (ASERF) toward improving the education of BII to restore health and balance and improve patient outcomes.

>> View on the Aesthetic Surgery Journal Open Forum Website
 
A Qualitative Study on the Experiences of Women With Breast Implant Illness Print

Samantha Tang, PhD; Natalie E. Anderson, PhD; Kate Faasse, PhD; William P. Adams Jr, MD; and Jill M. Newby, PhD

Aesthetic Surgery Journal, sjab215

Background: Breast implant illness (BII) is a term used to describe physical and psychological symptoms experienced by some women following breast implant surgery. Few studies have examined the experiences of women with BII—a poorly understood condition with no clear cause or treatment.

>> View on the Aesthetic Surgery Journal  Website

 
Non-Malignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step? Print

Marshall E. Kadin, MD; Haiying Xu, BA; Lisa M. Hunsicker, MD; and Yingjie Guan, MD, PhD

Aesthetic Surgery Journal
, sjab215

Background: CD30 lymphocyte activation antigen and phosphorylated STAT3 (pSTAT3) are consistent markers of tumor cells in breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). We present a case of BIA-ALCL in a breast implant capsule containing clustered tumor cells expressing CD30, pSTAT3, pSTAT6, interleukin 9, and granzyme B tumor cell biomarkers. Remarkably, the contralateral breast contained many scattered large, atypical CD30+ cells surrounded by inflammatory cells, raising a suspicion of bilateral BIA-ALCL, known to occur in some patients. To clarify the diagnosis, immunohistochemistry and multilabel immunofluorescence were performed. Unlike the tumor cells, the atypical CD30+ cells of the contralateral breast lacked pSTAT3, pSTAT6, interleukin 9, and granzyme B, eliminating a diagnosis of bilateral BIA-ALCL. This case highlights the importance of interpreting CD30 staining in the context of other tumor cell biomarkers and histopathology to avoid an incorrect diagnosis of BIA-ALCL. We believe the findings also suggest the possibility of CD30 expression as an early event in the multistep pathogenesis of BIA-ALCL.

>> View on the Aesthetic Surgery Journal  Website

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 4 of 15

"I GIVE..."

Dr. and Mrs.
Joseph M. Gryskiewicz
Burnsville, MN
 
“Corky and I contribute to plastic surgery research because we understand the need for funding to pave the way for new discoveries and to enhance patient safety."
 
"I am a long time member of the research committee. We are very frugal with how we apportion funds so I can assure you that your donation will be allotted wisely."

The Aesthetic Society


Copyright © 2009-2018 ASERF. 11262 Monarch St., Garden Grove, CA 92841-1441 P: 800-364-2147 F: 562-799-1098